Nuveen Asset Management LLC Sells 32,349 Shares of Transcat, Inc. (NASDAQ:TRNS)

Nuveen Asset Management LLC trimmed its stake in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 60.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,103 shares of the scientific and technical instruments company's stock after selling 32,349 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.23% of Transcat worth $2,231,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Jones Financial Companies Lllp lifted its stake in Transcat by 686.7% in the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock valued at $37,000 after purchasing an additional 309 shares during the last quarter. Aquatic Capital Management LLC raised its stake in shares of Transcat by 1,052.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock valued at $122,000 after buying an additional 1,052 shares during the period. Morgan Dempsey Capital Management LLC purchased a new position in shares of Transcat during the 4th quarter valued at $143,000. SG Americas Securities LLC purchased a new position in shares of Transcat during the 4th quarter valued at $182,000. Finally, KLP Kapitalforvaltning AS bought a new position in shares of Transcat during the 4th quarter worth $190,000. 98.34% of the stock is owned by institutional investors.

Transcat Price Performance

TRNS traded down $2.24 during trading on Friday, reaching $77.98. 91,772 shares of the company were exchanged, compared to its average volume of 84,291. Transcat, Inc. has a 12-month low of $67.56 and a 12-month high of $147.12. The company's 50-day moving average is $82.20 and its two-hundred day moving average is $88.30. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. The company has a market cap of $726.62 million, a price-to-earnings ratio of 42.15 and a beta of 0.75.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its quarterly earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing the consensus estimate of $0.66 by ($0.02). Transcat had a net margin of 6.22% and a return on equity of 7.23%. The company had revenue of $77.13 million for the quarter, compared to the consensus estimate of $76.40 million. The company's revenue was up 8.8% compared to the same quarter last year. Research analysts forecast that Transcat, Inc. will post 2.3 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

TRNS has been the topic of a number of research reports. HC Wainwright restated a "buy" rating and issued a $116.00 price objective (up from $106.00) on shares of Transcat in a research note on Wednesday, May 21st. Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a research report on Wednesday, May 28th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Transcat presently has an average rating of "Hold" and an average price target of $114.00.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.